Cargando…

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram

Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease associated with the Mediterranean fever (MEFV) gene and is mainly characterized by periodic fever and serositis. Colchicine has been used to prevent FMF episodes and reduce the frequency of attacks. We report the case of a 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toshida, Masamitsu, Konishi, Yuki, Ikenouchi, Atsuko, Okamoto, Naomichi, Yoshimura, Reiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214656/ https://www.ncbi.nlm.nih.gov/pubmed/34164245 http://dx.doi.org/10.7759/cureus.15145

Ejemplares similares

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Major depression with musical obsession treated with vortioxetine: a case report
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2020)

Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression
por: Yoshimura, Reiji, et al.
Publicado: (2021)

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder
por: Chibaatar, Enkhmurun, et al.
Publicado: (2023)

Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
por: Yoshimura, Reiji, et al.
Publicado: (2022)

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
por: Natsuyama, Tomoya, et al.
Publicado: (2023)

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Effect of the personality traits of healthy Japanese workers on depressive symptoms and social adaptation, and on the achievement rate of exercise therapy to prevent major depression
por: Ikenouchi, Atsuko, et al.
Publicado: (2023)

Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression
por: Tesen, Hirofumi, et al.
Publicado: (2022)

Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study
por: Okamoto, Naomichi, et al.
Publicado: (2021)

A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report
por: Okamoto, Naomichi, et al.
Publicado: (2021)

The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression
por: Yoshimura, Reiji, et al.
Publicado: (2023)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder
por: Ikenouchi, Atsuko, et al.
Publicado: (2021)

Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls
por: Fujii, Rintaro, et al.
Publicado: (2022)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder – RETRACTION
por: Ikenouchi, Atsuko, et al.
Publicado: (2022)

Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression
por: Ueda, Masashi, et al.
Publicado: (2020)

Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study
por: Seki, Issei, et al.
Publicado: (2023)

Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder
por: Watanabe, Keita, et al.
Publicado: (2022)

Acute pancreatitis during valproic acid administration in a patient with vascular dementia, epileptic seizures, and psychiatric symptoms: a case report
por: Yanaga, Mako, et al.
Publicado: (2023)

Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study
por: Okamoto, Naomichi, et al.
Publicado: (2022)

Increased Stimulation Intensity Helped to Cope with Prolonged Seizures During the Next Round of Modified Electroconvulsive Therapy: A Case Report
por: Katsumura, Tetsuya, et al.
Publicado: (2022)

Prolonged delirium caused by lithium poisoning in an endometrial cancer patient at advanced stage: A case report
por: Natsuyama, Tomoya, et al.
Publicado: (2023)

Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation
por: Hoshikawa, Takashi, et al.
Publicado: (2022)

Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra
por: Celebi, Zeynep Kendi, et al.
Publicado: (2014)

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
por: Calligaris, Lorenzo, et al.
Publicado: (2007)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
por: El Hasbani, Georges, et al.
Publicado: (2019)

Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
por: Sener, Seher, et al.
Publicado: (2023)

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study
por: Okamoto, Naomichi, et al.
Publicado: (2020)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
por: Köhler, Birgit Maria, et al.
Publicado: (2018)

Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
por: Berdeli, Afig, et al.
Publicado: (2019)

Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
por: Yücel, Burcu Bozkaya, et al.
Publicado: (2021)

Comparison of Different Pharmaceutical Preparations of Colchicine in Children with Familial Mediterranean Fever: Is Colchicine Opocalcium a Good Alternative?
por: Türkuçar, Serkan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b26qen1c8jjhgfv0e8p3jsfqei